News coverage about Healthequity (NASDAQ:HQY) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Healthequity earned a news impact score of 0.10 on Accern’s scale. Accern also assigned media stories about the company an impact score of 46.0134585630791 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Here are some of the news articles that may have impacted Accern Sentiment’s analysis:
Several research analysts recently commented on the company. KeyCorp lifted their price target on Healthequity from $66.00 to $72.00 and gave the stock an “overweight” rating in a research report on Thursday, April 5th. Zacks Investment Research lowered Healthequity from a “buy” rating to a “hold” rating in a research report on Wednesday, April 4th. ValuEngine upgraded Healthequity from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Cantor Fitzgerald restated a “buy” rating and set a $65.00 target price on shares of Healthequity in a research report on Friday, March 23rd. Finally, Barrington Research boosted their target price on Healthequity to $65.00 and gave the company an “outperform” rating in a research report on Tuesday, March 20th. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. Healthequity presently has an average rating of “Buy” and a consensus price target of $66.50.
Shares of NASDAQ:HQY opened at $64.20 on Tuesday. Healthequity has a 1 year low of $40.21 and a 1 year high of $68.75. The company has a market cap of $3,869.24, a price-to-earnings ratio of 118.89, a price-to-earnings-growth ratio of 2.54 and a beta of 1.39.
Healthequity (NASDAQ:HQY) last announced its earnings results on Monday, March 19th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.06. Healthequity had a return on equity of 13.47% and a net margin of 20.64%. The business had revenue of $60.44 million during the quarter, compared to analyst estimates of $58.46 million. equities research analysts forecast that Healthequity will post 0.77 EPS for the current fiscal year.
In other news, VP Darcy G. Mott sold 9,500 shares of Healthequity stock in a transaction that occurred on Monday, January 22nd. The shares were sold at an average price of $48.00, for a total transaction of $456,000.00. Following the completion of the sale, the vice president now owns 99,500 shares of the company’s stock, valued at $4,776,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Ashley Dreier sold 12,000 shares of Healthequity stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $52.00, for a total transaction of $624,000.00. Following the sale, the vice president now directly owns 17,652 shares of the company’s stock, valued at approximately $917,904. The disclosure for this sale can be found here. Insiders have sold 750,831 shares of company stock valued at $40,420,618 in the last 90 days. Company insiders own 19.00% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This article was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/17/healthequity-hqy-receives-coverage-optimism-score-of-0-10.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.